Eye Care References

July 19, 2004 - Natural Products Industry INSIDER
"Eye Health" References

1. The Eye Diseases Prevalence Research Group. "Causes and Prevalence ofVisual Impairment Among Adults in the United States." Arch Ophthalmol. 122:477-485,2004. http://archopht.ama-assn.org/

2. Age-Related Eye Disease Study Research Group. "A randomized,placebo-controlled, clinical trial of high-dose supplementation with vitamins Cand E, beta-carotene and zinc for age-related macular degeneration and visionloss: AREDS report no. 8." Arch Ophthalmol. 119, 10:1417-36, 2001.

3. Age-Related Eye Disease Study Research Group. "A randomized,placebo-controlled, clinical trial of high-dose supplementation with vitamins Cand E and beta-carotene for age-related cataract and vision loss: AREDS reportno. 9." Arch Ophthalmol. 119, 10:1439-52, 2001.

4. Age-Related Eye Disease Study Research Group. "Potential publichealth impact of Age-Related Eye Disease Study results: AREDS report no.11." Arch Ophthalmol. 121, 11:1621-4, 2003.

5. Chang CW et al. "Current use of dietary supplements in patients withage-related macular degeneration." Can J Ophthalmol. 38, 1:27-32,2003

6. Flood V et al. "Dietary antioxidant intake and incidence of earlyage-related maculopathy." Ophthalmology. 109, 12:2272-8, 2002.

7. Falsini B et al. "Influence of short-term antioxidant supplementationon macular function in age-related maculopathy: a pilot study includingelectrophysiologic assessment." Ophthalmology. 110, 1:51-60, 2003.

8. Mares-Perlman JA et al. "Vitamin supplement use and incidentcataracts in a population-based study." Arch Ophthalmol. 118,11:1556-63, 2000.

9. Reddy GB et al. "Reduced levels of rat lens antioxidant vitamins uponin vitro UVB irradiation." J Nutr Biochem. 12, 2:121-24, 2001.

10. Taylor A et al. "Long-term intake of vitamins and carotenoids andodds of early age-related cortical and posterior subcapsular lensopacities." Am J Clin Nutr. 75, 3:540-9, 2002.

11. Hegde KR, Varma SD. "Protective effect of ascorbate againstoxidative stress in the mouse lens." Biochim Biophys Acta. 1670,1:12-8, 2004.

12. Erb C et al. "Ascorbic acid as a free radical scavenger in porcineand bovine aqueous humour." Ophthalmic Res. 36, 1:38-42, 2004.

13. Ohta Y et al. "Prolonged marginal ascorbic acid deficiency inducesoxidative stress in retina of guinea pigs." Int J Vitam Nutr Res.72, 2:63-70, 2002.

14. Kojima M et al. "Low vitamin E level as a subliminal risk factor ina rat model of prednisolone-induced cataract." Invest Ophthalmol Vis Sci.43, 4:1116-20, 2002.

15. Ohta Y et al. "Preventive effect of vitamin E-containing liposomeinstillation on cataract progression in 12-month-old rats fed a 25% galactosediet." J Ocul Pharmacol Ther. 16, 4:323-35, 2000.

16. Naziroglu M, Karaoglu A, Aksoy AO. "Selenium and high dose vitamin Eadministration protects cisplatin-induced oxidative damage to renal, liver andlens tissues in rats." Toxicology. 195, 2-3:221-30, 2004.

17. Fujikawa A, Gong H, Amemiya T. "Vitamin E prevents changes in thecornea and conjunctiva due to vitamin A deficiency." Graefes Arch ClinExp Ophthalmol. 241, 4:287-97, 2003.

18. Underwood BA. "Vitamin A deficiency disorders: international effortsto control a preventable 'pox'." J Nutr. 134, 1:231S-236S, 2004.

19. Kanazawa S et al. "Interaction of zinc and vitamin A on the ocularsurface." Graefes Arch Clin Exp Ophthalmol. 240, 12:1011-21, 2002.

20. Obrosova IG et al. "Antioxidants attenuate early up regulation ofretinal vascular endothelial growth factor in streptozotocin-diabeticrats." Diabetologia. 44, 9:1102-10, 2001.

21. Borenshtein D et al. "Cataract development in diabetic sand ratstreated with alpha-lipoic acid and its gamma-linolenic acid conjugate." DiabetesMetab Res Rev. 17, 1:44-50, 2001.

22. Johnson EJ. "The role of carotenoids in human health." NutrClin Care. 5, 2:56-65, 2002.

23. Wooten BR, Hammond BR. "Macular pigment: influences on visual acuityand visibility." Prog Retin Eye Res. 21, 2:225-40, 2002.

24. Krinsky NI, Landrum JT, Bone RA. "Biological mechanisms of theprotective role of lutein and zeaxanthin in the eye." Annu Rev Nutr.23:171-201, 2003.

25. Curran-Celentano J et al. "Relation between dietary intake, serumconcentrations and retinal concentrations of lutein and zeaxanthin in adults ina Midwest population." Am J Clin Nutr. 74, 6:796-802, 2001.

26. Borekmans WM et al. "Macular pigment density in relation to serumand adipose tissue concentrations of lutein and serum concentrations ofzeaxanthin." Am J Clin Nutr. 76, 3:595-603, 2002.

27. Johnson EJ et al. "Relation among serum and tissue concentrations oflutein and zeaxanthin and macular pigment density." Am J Clin Nutr.71, 6:1555-62, 2000.

28. Granado F, Olmedilla B, Blanco I. "Nutritional and clinicalsignificance of lutein in human health." Br J Nutr. 90, 3:487-502,2003.

29. Alves-Rodrigues A, Shao A. "The science behind lutein." ToxicolLett. 150, 1:57-83, 2004.

30. Richer S et al. "Double-masked, placebo-controlled, randomized trialof lutein and antioxidant supplementation in the intervention of atrophicage-related macular degeneration: the Veterans LAST study (Lutein AntioxidantSupplementation Trial)." Optometry. 75, 4:216-30, 2004.

31. Koh HH et al. "Plasma and macular responses to lutein supplement insubjects with and without age-related maculopathy: a pilot study." ExperimentalEye Res. 79:21-27, 2004.

32. Toyoda Y et al. "Effect of dietary zeaxanthin on tissue distributionof zeaxanthin and lutein in quail." Invest Ophthalmol Vis Sci. 43,4:1210-21, 2002.

33. Thomson LR et al. "Elevated retinal zeaxanthin and prevention oflight-induced photoreceptor cell death in quail." Invest Ophthalmol VisSci. 43, 11:3538-49, 2002.

34. Breithaupt DE et al. "Comparison of plasma responses in humansubjects after the ingestion of 3R,3R'-zeaxanthin dipalmitate from wolfberry(Lycium barbarum) and non-esterified 3R,3R'-zeaxanthin using chiralhigh-performance liquid chromatography." Br J Nutr. 91, 5:707-13,2004.

35. Ohgami K et al. "Effects of astaxanthin onlipopolysaccharide-induced inflammation in vitro and in vivo." InvestOphthalmol Vis Sci. 44, 6:2694-701, 2003.

36. Wu TH et al. "An astaxanthin-containing algal extract attenuatesselenite-induced nuclear cataract formation in rat pups." ExperimentalBiology, 2002.

37. Matsumoto H et al. "Stimulatory effect of cyaniding 3-glycosides onthe regeneration of rhodopsin." J Agric Food Chem. 51, 12:3560-3,2003.

38. Nakaishi H et al. "Effects of black current anthocyanoside intake ondark adaptation and VDT work-induced transient refractive alteration in healthyhumans." Altern Med Rev. 5, 6:553-62, 2000.

39. Canter PH, Ernst E. "Anthocyanosides of Vaccinium myrtillus(bilberry) for night vision--a systematic review of placebo-controlledtrials." Surv Ophthalmol. 49, 1:38-50, 2004.

40. Kajimoto O. et al. Scient Rep Collect. 19:1, 1998.

41. Bagchi M et al. "Antioxidant and anticarcinogenic properties ofedible berry anthocyanins." The Original Internist. 10:6-14, 2003.

42. Schonlau F, Rohdewald P. "Pycnogenol for diabetic retinopathy: areview." Int Ophthalmol. 24, 3:161-71, 2001.

43. Rhee DJ et al. "Complementary and alternative medicine forglaucoma." Surv Ophthalmol. 46, 1:43-55, 2001.

44. Ritch R. "Potential role for Ginkgo biloba extract in the treatmentof glaucoma." Med Hypothesis. 54, 2:221-35, 2000.

45. Thiagarajan G et al. "Molecular and cellular assessment of ginkgobiloba extract as a possible ophthalmic drug." Exp Eye Res. 75,4:421-30, 2002.

46. Fies P, Dienel A. "[Ginkgo extract in impaired vision--treatmentwith special extract EGb 761 of impaired vision due to dry senile maculardegeneration.]" Wien Med Wochenschr. 152, 15-16:423-6, 2002.

47. Hirooka K et al. "The Ginkgo biloba extract (EGb 761) provides aneuroprotective effect on retinal ganglion cells in a rat model of chronicglaucoma." Curr Eye Res. 28, 3:153-7, 2004.

48. Seddon JM et al. "Dietary fat and risk for advanced age-relatedmacular degeneration." Arch Ophthalmol. 119, 8:1191-9, 2001.

49. Seddon JM, Cote J, Rosner B. "Progression of age-related maculardegeneration: association with dietary fat, transunsaturated fat, nuts and fishintake." Arch Ophthalmol. 121, 12:1728-37, 2003.

50. Jeffrey BG et al. "The role of docosahexaenoic acid in retinalfunction." Lipids. 36, 9:859-71, 2001.

51. Polit L et al. "Effects of docosahexaenoic acid on retinaldevelopment: cellular and molecular aspects." Lipids. 36, 9:927-35,2001.

52. Nishizawa C et al. "Effect of dietary DHA on DHA levels in retinalrod outer segments in young versus mature rats." Int J Vitam Nutr Res.73, 4:259-65, 2003.

53. Xi ZP, Wang JY. "Effect of dietary n-3 fatty acids on thecomposition of long- and very-long-chain polyenoic fatty acid in ratretina." J Nutr Sci Vitaminol (Tokyo). 49, 3:210-3, 2003.